Cardiac biomarkers are essential tools for risk stratification in both clinical practice and epidemiological research. By measuring levels of biomarkers, healthcare providers can categorize patients into different risk groups, enabling tailored treatment approaches. This stratification helps in predicting outcomes and in designing preventive strategies for high-risk populations.
